Company: OSRH
Filing Date: 2025-08-19
Form Type: PRE 14A
Source: 0001213900-25-078140
Chunk: 23

Company: OSR Holdings, Inc.
Filing Date: 2025-08-19
Form: PRE 14A
Chunk 23
---
as an Analyst and Portfolio Manager at Scudder Kemper and Schroders based in Seoul, Korea serving from 1998 to 2002. Mr. Jee has
received his B.A. in Business Administration from the Korea University in 1994.

Mr. Jee is well qualified to serve as a Director because
of his well-balanced career between finance and biopharmaceutical industries, especially leading M&A transactions while serving
from executive positions with his previous employer.

<div align='center'>11</div>

Dr. Joong Myung Cho became a Director of the
Company upon the Closing of the Business Combination. Dr. Cho has been Chairman and CEO of CG Pharmaceuticals, Inc. since October 2008
and previously served as Chairman and CEO of Hwail Pharmaceuticals Co. Ltd. from August 2013 to December 2022. Dr. Cho
is the founder of Crystal Genomics and the former Chairman & President (July 2000 to March 2023). He has over 40 years
of experience in biopharmaceutical industry covering from discovery of novel pharmaceuticals through R&D and commercialization. Dr. Cho
has previously served as the executive Senior Vice President and Director of R&D Biotech Research Institute at LG Life Science (formerly
LG Chem.) from 1984 to 2000. During his tenure, biopharmaceutical R&D at LG became the leading life science company in Korea where
it grew from just a few research scientists to several hundred prior to his departure. He has successfully introduced 10 different recombinant
products such as growth hormones of human, bovine, and porcine, hepatitis B vaccine, interferon alpha and gamma, GM-CSF, EPO, etc. Moreover,
four drug candidates were licensed out to multinational pharmaceutical companies under his supervision and one of them is approved by
FDA (US). On the basis of such achievements, Dr. Cho has received many awards and acted as a member of governmental committees. He
received his Ph.D. from University of Houston and worked as a post-doc in Baylor College of Medicine. Dr. Cho is an author of
more than 80 publications in books and journals including Nature, and an inventor of more than 200 patents filed. Dr. Cho is well
qualified to serve as a Director because of long-standing career experiences both as a biotech entrepreneur and the R&D Head
of a major life sciences company in Korea (LG Group).

Reto Fierz, is a Swiss entrepreneur